Noramco Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Noramco Inc (Noramco), a subsidiary of Johnson & Johnson is a manufacturer and distributor of bulk active ingredients. The companys products comprise amphetamine L aspartate, amphetamine sulfate, dextroamphetamine saccharate, dextroamphetamine sulfate, buprenorphine base, buprenorphine HCL, hydromorphone HCL, methylphenidate HCL, naloxone HCL, oxycodone base, and oxymorphone HCL products. It also manufactures thebaine, oripavine, oxycodone, hydrocodone, hydromorphone, oxymorphone, buprenorphinr and Nal components. Noramoco offers services such as global supply chain services, manufacturing facilities operations, robust processing, patent protected technology, product designing and development, and customer support services. The company has its presence in the US, Switzerland, the UK, Belgium, and Australia. Noramco is headquartered in Wilmington, Delaware, the US.

Noramco Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Noramco Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Noramco Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Noramco Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
RespireRx Pharma to Enter into Agreement Noramco 10
Noramco and SPI Pharma Enter into Agreement 11
Acquisition 12
Johnson and Johnson May Sell Noramco 12
Noramco Inc - Key Competitors 13
Noramco Inc - Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List Of Tables


Noramco Inc, Pharmaceuticals & Healthcare, Key Facts 2
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Noramco Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Noramco Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Noramco Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
RespireRx Pharma to Enter into Agreement Noramco 10
Noramco and SPI Pharma Enter into Agreement 11
Johnson and Johnson May Sell Noramco 12
Noramco Inc, Key Competitors 13

List Of Figures


Noramco Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Noramco Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Noramco Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Noramco Inc (Noramco), a subsidiary of Johnson & Johnson is a manufacturer and distributor of bulk active ingredients. The companys products comprise amphetamine L aspartate, amphetamine sulfate, dextroamphetamine saccharate, dextroamphetamine

USD 250 View Report

New Gold Inc - Strategy, SWOT and Corporate Finance Report

New Gold Inc - Strategy, SWOT and Corporate Finance ReportNew Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Infogroup Inc - Strategy, SWOT and Corporate Finance Report

Infogroup Inc - Strategy, SWOT and Corporate Finance ReportInfogroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the

USD 175 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available